Ascendis Pharma A (ASND) Change in Cash (2014 - 2026)

Ascendis Pharma A has disclosed Change in Cash across 13 years of filings, most recently posting -$60.1 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$60.1 million, down 72.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.9 million (down 73.92% YoY), and the FY2025 annual result was $95.1 million, down 57.98% from the prior year.
• Change in Cash came in at -$60.1 million for Q1 2026 at Ascendis Pharma A, down from $91.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $407.7 million in Q3 2024 to a low of -$144.0 million in Q4 2022.
• The 5-year median for Change in Cash is -$34.8 million (2025), against an average of $12.5 million.
• Peak annual rise in Change in Cash reached 816.62% in 2024, while the deepest fall reached 222.3% in 2024.
• Ascendis Pharma A's Change in Cash stood at -$144.0 million in 2022, then surged by 68.71% to -$45.1 million in 2023, then jumped by 52.13% to -$21.6 million in 2024, then soared by 523.83% to $91.4 million in 2025, then slumped by 165.72% to -$60.1 million in 2026.
• The last three Change in Cash figures came in at -$60.1 million (Q1 2026), $91.4 million (Q4 2025), and $47.9 million (Q3 2025), per Business Quant data.